These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 16630405

  • 1. Enhancement of antiangiogenic effects of human canstatin with a hypoxia-regulated transgene vector in lung cancer model.
    Li YY, Qian GS, Huang GJ, Chen F, Qian P, Yu SC, Wang CZ, Li Q, Wang JC, Wu GM.
    Cancer J; 2006; 12(2):136-46. PubMed ID: 16630405
    [Abstract] [Full Text] [Related]

  • 2. Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and canstatin gene suppression therapy on breast tumor xenograft growth in mice.
    Wang WB, Zhou YL, Heng DF, Miao CH, Cao YL.
    Breast Cancer Res Treat; 2008 Jul; 110(2):283-95. PubMed ID: 17899369
    [Abstract] [Full Text] [Related]

  • 3. [Reconstruction of adenovirus vector contained canstatin gene and hTERT gene core promoter and its anti-tumor effect in human ovarian cancer].
    Zhu BJ, Qiao YH, Li Y.
    Zhonghua Fu Chan Ke Za Zhi; 2009 Mar; 44(3):214-8. PubMed ID: 19570449
    [Abstract] [Full Text] [Related]

  • 4. [HSV-TK gene therapy of lung adenocarcinoma xenografts using a hypoxia/radiation dual-sensitive promoter].
    Wang WD, Chen ZT, Li DZ, Duan YZ, Wang ZX, Cao ZH.
    Ai Zheng; 2004 Jul; 23(7):788-93. PubMed ID: 15248913
    [Abstract] [Full Text] [Related]

  • 5. A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin.
    Xiao F, Wei Y, Yang L, Zhao X, Tian L, Ding Z, Yuan S, Lou Y, Liu F, Wen Y, Li J, Deng H, Kang B, Mao Y, Lei S, He Q, Su J, Lu Y, Niu T, Hou J, Huang MJ.
    Gene Ther; 2002 Sep; 9(18):1207-13. PubMed ID: 12215887
    [Abstract] [Full Text] [Related]

  • 6. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells.
    He GA, Luo JX, Zhang TY, Hu ZS, Wang FY.
    Biochem Biophys Res Commun; 2004 May 28; 318(2):354-60. PubMed ID: 15120609
    [Abstract] [Full Text] [Related]

  • 7. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach.
    Tao J, Tu YT, Huang CZ, Feng AP, Wu Q, Lian YJ, Zhang LX, Zhang XP, Shen GX.
    Br J Dermatol; 2005 Oct 28; 153(4):715-24. PubMed ID: 16181451
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Canstatin-N fragment inhibits in vitro endothelial cell proliferation and suppresses in vivo tumor growth.
    He GA, Luo JX, Zhang TY, Wang FY, Li RF.
    Biochem Biophys Res Commun; 2003 Dec 19; 312(3):801-5. PubMed ID: 14680836
    [Abstract] [Full Text] [Related]

  • 11. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ, Kong MJ, Ma ZY, Qian JF, Fan JQ, Xu XH.
    Zhonghua Yi Xue Za Zhi; 2007 Jun 05; 87(21):1506-9. PubMed ID: 17785094
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
    Izawa JI, Sweeney P, Perrotte P, Kedar D, Dong Z, Slaton JW, Karashima T, Inoue K, Benedict WF, Dinney CP.
    Clin Cancer Res; 2002 Apr 05; 8(4):1258-70. PubMed ID: 11948141
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Oncostatin M gene therapy in mice bearing lung adenocarcinoma xenograft using a hypoxia/radiation dual-sensitive promoter].
    Wang WD, Chen ZT, Li DZ, Duan YZ, Wang ZX, Cao ZH.
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Apr 05; 27(4):240-3. PubMed ID: 15144614
    [Abstract] [Full Text] [Related]

  • 17. Induction of tumor inhibition and apoptosis by a candidate tumor suppressor gene DRR1 on 3p21.1.
    Liu Q, Zhao XY, Bai RZ, Liang SF, Nie CL, Yuan Z, Wang CT, Wu Y, Chen LJ, Wei YQ.
    Oncol Rep; 2009 Nov 05; 22(5):1069-75. PubMed ID: 19787223
    [Abstract] [Full Text] [Related]

  • 18. [In vivo antitumor effect of canstatin gene on human esophageal carcinoma xenografts in nude mice].
    Zheng XW, Li Y, Tang FA, Ma J, Zheng PY, Lu GF.
    Ai Zheng; 2009 Apr 05; 28(4):350-5. PubMed ID: 19622292
    [Abstract] [Full Text] [Related]

  • 19. Cytotoxicity and antiangiogenesis by fibroblast growth factor 2-targeted Ad-TK cancer gene therapy.
    Saito K, Khan K, Sosnowski B, Li D, O'Malley BW.
    Laryngoscope; 2009 Apr 05; 119(4):665-74. PubMed ID: 19213040
    [Abstract] [Full Text] [Related]

  • 20. [Cloning of Human canstatin gene and expression of its recombinant protein].
    Li ZS, He XP, Tu ZX, Gao J, Pan X, Gong YF, Jin J.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct 05; 27(5):587-91. PubMed ID: 16274038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.